Search Results

Filter
  • 1-10 of  156,330 results for ""Clozapine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A study of the pharmacokinetics of clozapine and its metabolites by the dynamics of its distribution in the oral fluid of healthy volunteers.

  • Authors : Shi Q; School of Forensic Medicine, Shanxi Medical University, Jinzhong, 030600, Shanxi, China.; Key Laboratory of Forensic Medicine in Shanxi Province, Jinzhong, 030600, Shanxi, China.

Subjects: Clozapine*/Clozapine*/Clozapine*/analogs & derivatives ; Clozapine*/Clozapine*/Clozapine*/pharmacokinetics ; Clozapine*/Clozapine*/Clozapine*/administration & dosage

  • Source: Archives of toxicology [Arch Toxicol] 2024 Nov; Vol. 98 (11), pp. 3755-3761. Date of Electronic Publication: 2024 Aug 07.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0417615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Exploration of Clozapine-Induced Cardiomyopathy and Its Mechanism.

  • Authors : Zhang S; Department of Forensic Medicine, College of Basic Medicine, Chongqing Medical University, Medical College Road, Yuzhong District, Chongqing, China.; Jin P

Subjects: Clozapine*/Clozapine*/Clozapine*/toxicity ; Clozapine*/Clozapine*/Clozapine*/adverse effects ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/drug effects

  • Source: Cardiovascular toxicology [Cardiovasc Toxicol] 2024 Nov; Vol. 24 (11), pp. 1192-1203. Date of Electronic Publication: 2024 Aug 17.Publisher: Humana Press Country of Publication: United States NLM ID: 101135818 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission.

  • Authors : Okada M; Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu, Japan.; Fukuyama K

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacology ; Clozapine*/Clozapine*/Clozapine*/administration & dosage ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/pharmacology

  • Source: British journal of pharmacology [Br J Pharmacol] 2024 Nov; Vol. 181 (22), pp. 4571-4592. Date of Electronic Publication: 2024 Aug 02.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381

Record details

×
Academic Journal

Clozapine Toxicity Predictor: Deep neural network model predicting clozapine toxicity and its therapeutic dose range.

  • Authors : Wysokiński A; Medical University of Lodz, Department of Old Age Psychiatry and Psychotic Disorders, Czechosłowacka 8/10, 92-216 Łódź, Poland. Electronic address: .; Dreczka J

Subjects: Clozapine*/Clozapine*/Clozapine*/adverse effects ; Clozapine*/Clozapine*/Clozapine*/blood ; Clozapine*/Clozapine*/Clozapine*/analogs & derivatives

  • Source: Psychiatry research [Psychiatry Res] 2024 Dec; Vol. 342, pp. 116256. Date of Electronic Publication: 2024 Nov 05.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Ireland NLM ID: 7911385 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Improved insomnia is one pathway underlying the anti-suicidal properties of clozapine.

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/Sleep Initiation and Maintenance Disorders*/drug therapy ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use

  • Source: Suicide & life-threatening behavior [Suicide Life Threat Behav] 2024 Dec; Vol. 54 (6), pp. 972-981. Date of Electronic Publication: 2024 Jun 07.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7608054 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-term stability of five atypical antipsychotics (risperidone, olanzapine, paliperidone, clozapine, quetiapine) and the antidepressant mirtazapine in human serum assessed by a validated SPE LC-MS/MS method.

  • Authors : Fruekilde PBN; Dept. of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.; Nielsen F

Subjects: Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods ; Mirtazapine*/Mirtazapine*/Mirtazapine*/blood ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/blood

  • Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2024 Nov; Vol. 135 (5), pp. 607-619. Date of Electronic Publication: 2024 Sep 23.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

Record details

×
Academic Journal

The factors associated with clozapine polypharmacy for schizophrenia patients discharged from a large public psychiatric hospital in Taiwan, 2006-2021.

  • Authors : Shih YJ; Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, Kaohsiung, Taiwan.; Lin CH

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/administration & dosage

  • Source: Medicine [Medicine (Baltimore)] 2024 Dec 20; Vol. 103 (51), pp. e40897.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The relationship of cardiovascular disease risk, clozapine antipsychotic use and cognitive function in a large Chinese schizophrenia cohort.

  • Authors : Lu C; Department of Psychiatry, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin 300222, China; Institute of Mental Health, Tianjin Anding Hospital, Mental Health Center of Tianjin Medical University, Tianjin 300222, China.

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology

  • Source: Brain research [Brain Res] 2024 Dec 15; Vol. 1845, pp. 149220. Date of Electronic Publication: 2024 Aug 31.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 0045503 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effect of Organic Anion Transporting Polypeptide 1B1 on Plasma Concentration Dynamics of Clozapine in Patients with Treatment-Resistant Schizophrenia.

  • Authors : Sato T; Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai 980-8574, Japan.; Kawabata T

Subjects: Clozapine*/Clozapine*/Clozapine*/pharmacokinetics ; Clozapine*/Clozapine*/Clozapine*/blood ; Clozapine*/Clozapine*/Clozapine*/pharmacology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Dec 09; Vol. 25 (23). Date of Electronic Publication: 2024 Dec 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Therapeutic drug monitoring vs. pharmacogenetic testing in the context of elevated olanzapine concentrations and prior clozapine intolerability: a case study.

  • Authors : Khorassani F; University of California, Irvine, School of Pharmacy and Pharmaceutical Sciences, 802 W Peltason Dr, Irvine, CA, 92617, USA. .; Azevedo R

Subjects: Clozapine*/Clozapine*/Clozapine*/therapeutic use ; Clozapine*/Clozapine*/Clozapine*/adverse effects ; Clozapine*/Clozapine*/Clozapine*/pharmacokinetics

  • Source: BMC psychiatry [BMC Psychiatry] 2024 Dec 04; Vol. 24 (1), pp. 885. Date of Electronic Publication: 2024 Dec 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X

Record details

×
  • 1-10 of  156,330 results for ""Clozapine""